Inter & Co, Inc. (NASDAQ:INTR) is one of the 10 best financial stocks to buy for the long term. On January 26, Inter & Co, Inc. (NASDAQ:INTR) announced that its board had approved plans to begin ...

Hello, and welcome to Inter IR talks. I'm Rafaela Vitoria, Inter Investor Relations Officer, and this video cast is produced by the IR team in order to bring valuable insights into our business. Today ...

Paya Besar MP Shahar Abdullah said although many households are still struggling with the rising cost of living, cash aid is not a lasting fix and the government must implement further measures to ...

As of September 30, 2025, the average one-year price target for Inter is $8.45/share. The forecasts range from a low of $4.44 to a high of $10.29. The average price target represents a decrease of ...

Enthusiasm surrounds 'STR 49,' marking Silambarasan TR and Vetrimaaran's first collaboration. G.V. Prakash Kumar expressed interest in composing music, recalling his school rivalry with Simbu and past ...

Investors interested in Financial - Miscellaneous Services stocks are likely familiar with Inter & Co. Inc. (INTR) and American Express (AXP). But which of these two stocks offers value investors a ...

The GI tract is a complex group of organs, each of which helps your body digest and absorb food. Your upper GI tract includes your esophagus, stomach, and the first section of your small intestine, ...

Inter & Co. Inc. (INTR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Appendix cancer, also called appendiceal cancer, is when abnormal cells grow and form a tumor in the appendix. Your appendix is a little pouch-like organ attached to the lower right side of your large ...

Investors looking for stocks in the Financial - Miscellaneous Services sector might want to consider either Inter & Co. Inc. (INTR) or Blackstone Inc. (BX). But which of these two stocks presents ...

Once considered an outlier in gastrointestinal oncology, appendix cancer is now at the forefront of precision medicine, driven by genomic insights, personalized therapies, and a surge in scientific ...